FLX BIO
Dead / Cancelled — Cancelled — Section 8 (as of 12 Jul 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86943860
- Registration number
- 5365577
- Mark type
- Design + words
- Filed
- 17 Mar 2016
- Published for opposition
- 04 Oct 2016
- Registered
- 26 Dec 2017
- Attorney of record
- R. Gwen Peterson
Goods and services
- Class 042 — Scientific and technological services: The discovery, research, and development of therapeutics for the treatment and/or prevention of cancer-related and/or immune-related disorders; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals and therapeutics for the treatment of immuno-oncology - related disorders
Owner
- RAPT THERAPEUTICS, INC., SOUTH SAN FRANCISCO, CA, US
- FLX Bio, Inc., South San Francisco, CA, US
- FLX Bio, Inc., South San Francisco, CA, US
- FLX Bio, Inc., South San Francisco, CA, US
Prosecution history
- 12 Jul 2024 — CANCELLED SEC. 8 (6-YR)
- 26 Dec 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Jul 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 26 Dec 2017 — REGISTERED-PRINCIPAL REGISTER
- 21 Nov 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Nov 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Nov 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Nov 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Nov 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Aug 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Aug 2017 — NON-FINAL ACTION E-MAILED
- 30 Aug 2017 — SU - NON-FINAL ACTION - WRITTEN
- 24 Jun 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 25 May 2017 — USE AMENDMENT FILED